Rapid ART: An Essential Strategy to End the HIV Epidemic
Resource updated 03/15/2023
Resource updated 03/15/2023
Resource updated 09/19/2023
As HIV elimination activities increase, jurisdictions can address HIV/Hepatitis C (HCV) co-infection by enhancing HCV screening and treatment data collection. This session will discuss NASTAD's work with North Carolina to incorporate HCV data in CAREWare and electronic health records (EHRs), as well as recommendations for integrating HCV services into the HIV care infrastructure.
Resource (Conference Presentation) updated 09/14/2023
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
Panelists will describe collaborative prevention and support services provided to people with HIV and/or hepatitis from incarceration to re-entry. Services addressing social determinants of health are provided in corrections facilities and upon release. Panelists include the program director, staff from a correctional medical facility, and community-based organizations working inside and outside of correction facilities.
Resource (Conference Presentation) updated 09/14/2023
This session will help recipient and subrecipient sites to successfully connect their CAREWare and other electronic health information systems with external sources of data to report and monitor HIV care and treatment outcomes. This session will provide practical examples of successful data integration and highlight ongoing issues and costs in long-term management and maintenance.
Resource (Conference Presentation) updated 09/14/2023
HRSA/HAB guidance on using RWHAP funds to provide services to eligible individuals in prisons, jails, and other correctional systems allows recipients to determine which RWHAP services to provide and for how long. This session will provide overviews of HAB policy and two recipients' programs serving people who are justice-involved.
Resource (Conference Presentation) updated 09/14/2023
The presentation will describe how CAREWare and eligibility integration eased access to services by clients in our jurisdictions. Presenters will be to provide Ryan White jurisdictions with actionable ideas and processes to integrate their CAREWare and eligibility processes to improve access to services, reporting, monitoring, and quality management.
Resource (Conference Presentation) updated 09/14/2023
This session will discuss key considerations for RWHAP Part B programs and AIDS Drug Assistance Programs (ADAPs) as they support access to medication and related services for justice-involved individuals within the parameters of relevant HRSA/HAB guidance and other federal policies.
Resource (Conference Presentation) updated 09/14/2023
CAREWare users can provide input on all CAREWare 6 software components, including ease of use, design, reports, and other features. This session will address challenges with specific features like setup, administration, generating reports, and basic data entry.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023
The rate of HIV among people in US prisons is higher than the general population. This workshop will review an evidence-informed intervention to engage people with HIV in the jail setting. Challenges, strategies, and lessons learned will be discussed to support the adaptation and replication of the evidence-informed intervention.
Resource (Conference Presentation) updated 09/14/2023
Rapid initiation of antiretroviral therapy (ART) after diagnosis can increase the number of patients arriving for appointments, shorten time to viral suppression, and promote health equity. The presenters share key lessons learned through the implementation process at a large HIV clinic in the South with the theme of partnerships.
Resource (Conference Presentation) updated 09/14/2023
In December 2016 CrescentCare began linking individuals newly diagnosed with within 72-hours through the CrescentCare START Initiative. We compared linkage and viral suppression between those under and over 24 years old. We found similar successful outcomes for both age cohorts in our intervention.
Resource (Conference Presentation) updated 09/14/2023
Implementation of rapid antiretroviral therapy (ART) initiation is beset with clinical and process challenges. Three clinical providers will share their lessons learned from developing a program and delivering care in various care settings (pediatric, adult, and walk-in clinic).
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 12/11/2023
Rapid antiretroviral treatment (ART) initiation in the United States remained 'investigational' until the update in the Department of Health and Human Services guidelines (December 18, 2019). Centers for AIDS Research (CFARs) in D.C., the San Francisco Bay area, and Baltimore will share how they are working with their health departments and implementing partners, including Ryan White-funded clinics to address rapid ART implementation strategies.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 12/11/2023